Skip to main content
SpringerLink
Log in

Kontra: Geringer Nutzen bei relativ hoher Rezidiv-Rate

  • Fortbildung
  • Schwerpunkt Kardiologie
  • Published:
CardioVasc Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Iung B. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease Eur Heart J. 2003;24:1231–43

    Article  Google Scholar 

  2. Maisano F. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol. 2013;62(12):1052–61

    Article  Google Scholar 

  3. Puls M. One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry. Eur Heart J. 2016;37(8):703–12

    Article  Google Scholar 

  4. Feldman T. Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II. J Am Coll Cardiol. 2015;66:2844–54

    Article  Google Scholar 

  5. Obadia JF. Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation. N Engl J Med. 2018; 379:2297–306

    Article  Google Scholar 

  6. Stone GW. Transcathetermitral-valve repair in patients with heart failure. New Engl J Med. 2018;379:2307–18

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Charité - Campus Virchow Klinikum Medizinische Klinik m. S. Kardiologie, Deutsches Zentrum für Herz-Kreislauf-Forschung, Standort Berlin, Augustenburger Platz 1, 13353, Berlin, Deutschland

    Tobias Daniel Trippel,  Burkert Pieske &  Mohammad Sherif

Authors
  1. Tobias Daniel Trippel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Burkert Pieske
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohammad Sherif
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tobias Daniel Trippel.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Trippel, T.D., Pieske, B. & Sherif, M. Kontra: Geringer Nutzen bei relativ hoher Rezidiv-Rate. CV 19, 34–35 (2019). https://doi.org/10.1007/s15027-019-1599-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15027-019-1599-9

Search

Navigation